Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Boralex Highlights Key Strategies and New Directors at Meeting
- Groundbreaking Illinois Legislation for PAD Screening Coverage
- Persado's Innovative AI Sweetens Marketing Recognition for Gen Z
- Qatar Airways Partners with Boeing for Record Aircraft Order
- Linc Housing Commemorates New Affordable Housing Opening
- Serina Therapeutics Awards Stock Options to New Employees
- Grand Opening of Vermeer: A Luxurious Urban Retreat
- Nasdaq Celebrates Strengthened Corporate Governance in Texas
- Investment Company Institute Backs New Savings Accounts
- Empowering New York's Nursing Workforce for Better Care
- Investors Unite to Address Securities Fraud in Bitfarms Ltd.
- Protecting Vital Health Services Amid Medicaid Budget Cuts
- 5WPR Secures Gold Stevie Award for Innovative Campaign
- Venus Aerospace's Breakthrough in Hypersonic Flight Achieved
- Alpha-1 Foundation Marks 30 Years of Advancements in Care
- Go1 Transforms Learning Experience with Innovative Rebranding
- MultiBank Group Unveils Innovative Ecosystem for Digital Assets
- Nilörngruppen AB’s AGM: Key Decisions & Future Outlook
- Fiera Capital Raises Offering of Senior Debentures to $70 Million
- Critical One Energy Unveils High-Grade Antimony Findings
- Discover the Hawk+: Four Wheel Campers' Innovative Flatbed
- Global Collaboration for LGBTIQ+ Rights Elevates Inclusion Efforts
- TowneBank Declares Impressive Dividend Amid Growth Strategies
- Equinor ASA's Annual General Meeting Highlights and Insights
- Piramal Pharma Limited Reports Strong Q4 and FY2025 Growth
- Explore Unique Culinary Voyages with Atlas Ocean Experiences
- Quarterra Unveils The Ansel: Luxurious Living in Frisco
- Piramal Pharma Limited Reports Strong Financial Performance
- Marian University and BHOF Collaboration Enhances Bone Health
- ACEC Advocates for Stronger Infrastructure Investments Ahead
- Javier Loya's Impact at National Policy Summit Event
- Empower Your Cannabis Brand with DistruCommerce Innovation
- Elevate Your Wellness: Laird Superfood Introduces New Mushroom Powders
- Patrick McGee Partners with WWSG: Insights on Tech and Business
- Unlocking the Future: Hydrogen and Ammonia in Clean Energy
- Tim Lamb Group Navigates Successful Toyota Dealership Sale
- Exciting New Game Show Experience Debuts in Charlotte Area
- Key Insights Into the Expanding Hydrogen Storage Sector
- Celebrating 15 Years: Nex-Invest's Journey in Crypto Trading
- Breaking Ground in Quantum Technology: A New Joint Venture
- Hammes Earns Spot on Best Places to Work in Healthcare List
- NorthStar Care Community Partners with Medline for Excellence
- Women of Influence Conference: A Transformative Gathering
- Empowering FirstEnergy Customers to Manage Electric Costs
- Discover Wild Finch: A Culinary Gem in Pagosa Springs
- Reental Launches $REENTAL Trading on MEXC for Global Impact
- Unlock Passive Earnings with HashFly’s Cloud Mining in 2025
- Discover Kaanch: The Next Big Breakthrough in Blockchain
- Truxton Capital Advisors Facilitates Major Environmental Deal
- Joint Venture Between Quantinuum and Al Rabban Capital Transforms Quantum Innovation